Skip to main content
OpenTrials
Completed

NCT Number: NCT06506383

Coronary Artery Disease Mortality in Turkiye

This study aims to analyze the geographical variations and identify key environmental and behavioral predictors of coronary artery disease (CAD) mortality in Turkiye.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Istanbul Medipol University

Beykoz, Istanbul, 34810, Turkey (Türkiye)

About this study

A 10-year longitudinal province-level data was used to identify change trajectories of CAD mortality. . Environmental determinants (such as air quality and climatic conditions) and behavioral factors of alcohol consumption and smoking were examined for their association with CAD mortality change trajectories using Ordinal Logistic Regression models.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All citizens in a given province

Exclusion criteria

  • None

Treatment and study plan

No Intervention as this is an ecological study

Other

No Intervention as this is an ecological study

Primary outcomes

  1. CAD Mortality

    Time frame: 2010-2019

    coronary artery disease (CAD) mortality per 100,000 population

Sponsors and collaborators

Lead sponsor

Medipol University

Other

Registry information

Official study title

Geographical Variations and Predictors of Coronary Artery Disease Mortality in Turkiye: An Environmental and Behavioral Analysis

Important dates

Study start
2020
Primary completion
2022
Study completion
2023
First posted
Jul 17, 2024
Registry last updated
Jul 17, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.